XBIO xeneticbio.com Yakuniy foyda

xeneticbio.com (XBIO) korporativ emblemasi va logotipi

Xenetic Biosciences (XBIO) biotexnologiya sektoriga e'tibor qaratgan holda, onkologiyaga qarshi kurashish uchun hujayraviy platformalarni ishlab chiqadi. Kompaniyaning foydasi uning rivojlanishining joriy bosqichini aks ettiradi, bunda -0.00 belgisi asosiy ko'rsatkich bo'lib xizmat qiladi. O'sish potentsiali sog'liqni saqlash gigantlari tomonidan patentlarning litsenziyalanishiga asoslangan, garchi tijorat sotuvlarining yo'qligi va aksiyalar emissiyasiga tayanish kompaniyaning joriy moliyaviy profilini belgilab bersa-da.

XBIO (Xenetic Bio) Sof foyda tarixi 04.07.2022dan 01.11.2026gacha

xeneticbio.com (XBIO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Xenetic Biosciences, Inc.|XBIO - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Xenetic Biosciences, Inc.|XBIO - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- biznesning balans baholash tafsilotlari:
Aksiyaning buxgalteriya qiymati Xenetic Biosciences|XBIO - Balans kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati xeneticbio.com|XBIO - Kompaniyaning yakuniy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Xenetic Biosciences|XBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Xenetic Biosciences, Inc.|XBIO - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Xenetic Biosciences, Inc.|XBIO - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzdorligi Xenetic Biosciences|Shoshilinch likvidlik xeneticbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
XBIO - Kompaniyaning sof foydasi
Fundamental baholash:XBIO Xenetic Bio
Xenetic Biosciences Inc. ishlab chiqargan mahsulot

Investorlar yashirin xarajatlarni aniqlash uchun sof marja tahlilidan foydalanishlari va Xenetic Biosciences (XBIO) kompaniyasining yakuniy foyda dinamikasi orqali xavfsizlikning real zaxirasini baholashlari lozim. Xenetic Biosciences (XBIO) onkologik vaksinalariga bo'lgan talab makroiqtisodiy omillardan mustaqil bo'lganligi sababli, ushbu ko'rsatkich biznesning operatsion barqarorligini aks ettiradi, bunda barqaror daromad egri chizig'i inflyatsion zarbalardan qat'i nazar kompaniyaning ishonchliligini tasdiqlaydi.

Muhim raqobatchilar

Kompaniyaning sof daromadi BeiGene Oncology (ONC)|Kompaniyaning sof foydasi Halozyme Therapeutics|RVMD: Yakuniy foyda|Sof daromad AAPG (Ascentage Pharma)|CGON (CG Oncology Inc) - Yakuniy foyda|Sof foyda URGN (UroGen)|BCAX - Sof daromad|PSNL: Sof daromad|ERAS - Sof foyda|Delcath Systems (DCTH) - Kompaniyaning sof foydasi|Y-mAbs Therapeutics Inc - Yakuniy foyda|AURA (Aura Bio) - Sof foyda|Kompaniyaning sof daromadi Candel CADL|Sof daromad ARAY (Accuray Incorporated)|sellaslifesciences.com - Kompaniya foydasi|Sof foyda ACTU (Actuate Therapeutics)|Citius Oncology Inc. (CTOR) - Kompaniyaning sof daromadi|HURA - Kompaniyaning sof foydasi|TARA (Protara Tx) - Kompaniya foydasi|FATE: Sof foyda|Kompaniyaning sof daromadi Aadi Bioscience (WHWK)|Sof daromad TCRX|CSBR (Champions Oncology Corp) - Soliqlar to‘langandan keyingi foyda|Sof foyda XBIT|Sof moliyaviy natija cel-sci.com|Sof foyda OSTX (OS Therapies Incorporated)|RADX - Sof daromad|ARTV: Sof daromad|Yakuniy foyda ANL (Adlai Nortye Ltd.)|VERU: Sof foyda|TPST (Tempest Therapeutics Corp) - Kompaniyaning sof foydasi|XLO (Xilio Therapeutics Inc) - Sof foyda|Enochian BioSciences (RENB) - Sof moliyaviy natija|Kompaniyaning sof foydasi Mural Oncology plc (MURA)|KAPA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi OnKure Therapeutics OKUR|Sof moliyaviy natija CytoMed Therapeutics Ltd (GDTC)|Curis Corp - Sof foyda|Apollomics, Inc. (APLM) - Sof daromad|THAR: Sof foyda|ADVB - Sof moliyaviy natija|GNPX (Genprex, Inc) - Sof foyda|Kompaniyaning sof daromadi Calidi Bio CLDI|Kompaniyaning sof foydasi Sunshine Biopharma (SBFM)|salariuspharma.com - Kompaniya foydasi|Sof foyda PPBT (Purple Biotech Ltd.)|AONC - Sof daromad|BeOne Medicines - Sof foyda|Kompaniyaning sof daromadi Checkpoint Therapeutics Inc|Elevation Oncology, Inc. (ELEV) - Kompaniyaning sof foydasi|ICAD - Sof moliyaviy natija|Sof daromad IKNA|Kompaniya foydasi NTBL (Notable Labs Ltd)|Sof foyda VIRX|Kompaniyaning sof foydasi MOR (MorphoSys Corporation)|Sof foyda NAYA (NAYA Biosciences)|Sof moliyaviy natija ascentage.com (AAPGV)